Rhythm Pharmaceuticals
RYTM
#2254
Rank
A$12.31 B
Marketcap
A$177.67
Share price
2.08%
Change (1 day)
15.06%
Change (1 year)

Earnings for Rhythm Pharmaceuticals (RYTM)

Earnings in 2026 (TTM): -A$0.28 Billion

According to Rhythm Pharmaceuticals's latest financial reports the company's current earnings are A$0.28 Billion. In 2025 the company made an earning of -A$0.3 Billion, an increase over its 2024 earnings that were of -A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rhythm Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.28 Billion-4.33%
2025 -A$0.3 Billion-24.66%
2024 -A$0.39 Billion41.34%
2023 -A$0.28 Billion1.65%
2022 -A$0.28 Billion160.18%
2021 -A$0.11 Billion-48.05%
2020 -A$0.2 Billion-4.78%
2019 -A$0.22 Billion90.01%
2018 -A$0.12 Billion119.72%
2017 -A$50.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-18.78%๐Ÿ‡บ๐Ÿ‡ธ USA